ATE490972T1 - Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven - Google Patents

Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven

Info

Publication number
ATE490972T1
ATE490972T1 AT02770017T AT02770017T ATE490972T1 AT E490972 T1 ATE490972 T1 AT E490972T1 AT 02770017 T AT02770017 T AT 02770017T AT 02770017 T AT02770017 T AT 02770017T AT E490972 T1 ATE490972 T1 AT E490972T1
Authority
AT
Austria
Prior art keywords
biologically active
active peptides
injured nerves
laminin
repairing injured
Prior art date
Application number
AT02770017T
Other languages
English (en)
Inventor
Paeivi Liesi
Original Assignee
Paeivi Liesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paeivi Liesi filed Critical Paeivi Liesi
Application granted granted Critical
Publication of ATE490972T1 publication Critical patent/ATE490972T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02770017T 2001-10-26 2002-10-25 Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven ATE490972T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20012082A FI20012082A0 (fi) 2001-10-26 2001-10-26 Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
PCT/FI2002/000831 WO2003035675A1 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves

Publications (1)

Publication Number Publication Date
ATE490972T1 true ATE490972T1 (de) 2010-12-15

Family

ID=8562134

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02770017T ATE490972T1 (de) 2001-10-26 2002-10-25 Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven

Country Status (10)

Country Link
US (3) US20040266991A1 (de)
EP (1) EP1438329B1 (de)
JP (1) JP4312054B2 (de)
AT (1) ATE490972T1 (de)
AU (1) AU2002336124B2 (de)
CA (1) CA2465245C (de)
DE (1) DE60238551D1 (de)
DK (1) DK1438329T3 (de)
FI (1) FI20012082A0 (de)
WO (1) WO2003035675A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029468A1 (de) * 2005-06-24 2006-12-28 Plt Patent & Licence Trading Ltd. Verwendung von Inhibitoren der N-Methyltransferasen in der Therapie des Parkinson-Syndroms
RU2301678C1 (ru) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
WO2008150475A1 (en) * 2007-05-31 2008-12-11 The Hertz Corporation System and method for automatically generating an airplane boarding pass for a traveler returning a rental car
US8008253B2 (en) * 2007-07-03 2011-08-30 Andrew Tasker Treatment for anxiety
WO2009114539A2 (en) * 2008-03-10 2009-09-17 University Of Louisville Research Foundation Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
GB201700529D0 (en) * 2017-01-12 2017-03-01 Rogers April Laminin receptor peptide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT276041B (de) * 1968-08-16 1969-11-10 Dragoco Gerberding Co Gmbh Verfahren zur Herstellung eines konzentrierten, praktisch sterilen Rohzwiebelaromas
US3590722A (en) * 1969-06-09 1971-07-06 Samuel Leptrone Flavor injector device
HU185263B (en) 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
FI922517A7 (fi) * 1992-05-29 1993-11-30 Liesi Paeivi Väline hermojen korjaamiseksi, ja sen käyttö
GB9217316D0 (en) 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use
GB9324473D0 (en) 1993-11-29 1994-01-12 Oxford Res Support Co Ltd Isolation of streptokinase by affinity chromatography
ES2185782T3 (es) * 1995-07-26 2003-05-01 Firmenich & Cie Productos aromatizados y procedimiento para su preparacion.
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
CA2307954C (en) 1997-04-03 2010-07-13 California Institute Of Technology Enzyme-medicated modification of fibrin for tissue engineering
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
IL121191A0 (en) * 1997-06-29 1997-11-20 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
MXPA01010692A (es) 1999-04-22 2004-09-06 Univ Zuerich Matrices de proteina modificadas para ingenieria de tejidos o liberacion controlada.
DE20010297U1 (de) 2000-06-08 2000-08-31 ETH Zürich, Zürich Enzymvermittelte Modifizierung von Fibrin zur Gewebemanipulation: Fibrin-Formulierungen mit Peptiden

Also Published As

Publication number Publication date
DE60238551D1 (de) 2011-01-20
WO2003035675A1 (en) 2003-05-01
EP1438329B1 (de) 2010-12-08
AU2002336124B2 (en) 2008-07-03
CA2465245C (en) 2012-09-11
US7741436B2 (en) 2010-06-22
US20080249021A1 (en) 2008-10-09
JP2005512979A (ja) 2005-05-12
US20050288231A1 (en) 2005-12-29
US7659255B2 (en) 2010-02-09
CA2465245A1 (en) 2003-05-01
US20040266991A1 (en) 2004-12-30
JP4312054B2 (ja) 2009-08-12
EP1438329A1 (de) 2004-07-21
DK1438329T3 (da) 2011-03-28
FI20012082A0 (fi) 2001-10-26

Similar Documents

Publication Publication Date Title
ATE314860T1 (de) Verwendung des copolymer-1 peptids sowie von damit verwandten peptiden und polypeptiden und von damit behandelten t-zellen zur neuroprotektion vor glutamattoxizitaet
CY1111120T1 (el) Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση
PL370891A1 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
ATE383865T1 (de) Apolipoprotein a-i agonisten und deren verwendung zur behandlung dyslipidämischer erkrankungen
DE69938507D1 (en) Fragment des "connective tissue growth factor" (ctgf)
ATE353914T1 (de) Peptide zur behandlung von tumoren und anderen bedingungen die die entfernung oder zerstörung von zelle erfordern
MXPA02006885A (es) Bloqueo del crecimiento axonal mediado por receptor de nogo.
DE69922819D1 (de) Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie
ATE459644T1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
DE60238551D1 (de) Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven
ATE259652T1 (de) Neuronale verwendungen des bmp-11
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
ATE193305T1 (de) Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
EP0917535A4 (de) Neuroaktive peptide
DE69509673D1 (de) Peptide zur behandlung von allergien
HK1044546A1 (zh) Prosaposin衍生反转肽及其用途
WO1999062931A3 (en) A cell density signal protein suitable for treatment of connective tissue injuries and defects
EP1714979A3 (de) Peptide für die Behandlung von Tumoren und anderen Zuständen, die das entfernen oder zerstören von Zellen erfordern
DE60221718D1 (de) Eine, ein peptid und ein pigment enthaltende zusammensetzung und deren verwendung zur hautbräunung
EP1847550A3 (de) Peptide zur effektiven Behandlung von Tumoren und anderen Bedingungen, die Zellentfernung oder- zerstörung erfordern
MX9800686A (es) Nueva proteina hmw humana mp52s.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties